1. Spinal cord ependymoma: a review of the literature and case series of ten patients

   • Emma Celano
   • Arsalaan Salehani
   • Constantinos G. Hadjipanayis

   Topic Review 06 May 2016 Pages: 377 - 386

   

2. State of affairs in use of steroids in diffuse intrinsic pontine glioma: an international survey and a review of the literature

   • Sophie E. M. Veldhuijzen van Zanten
   • Ofelia Cruz
   • SIOPE DIPG Network

   Topic Review Open access 13 May 2016 Pages: 387 - 394

   

3. Shift of microRNA profile upon orthotopic xenografting of glioblastoma spheroid cultures

   • Bo Halle
   • Mads Thomassen
   • Bjarne W. Kristensen

   Laboratory Investigation 11 April 2016 Pages: 395 - 404

   

4. Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study

   • Shamik Chakraborty
   • Christopher G. Filippi
   • John A. Boockvar

   Clinical Study 05 March 2016 Pages: 405 - 415

   

5. Erratum to: Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study

   • Shamik Chakraborty
   • Christopher G. Filippi
   • John A. Boockvar

   Erratum 06 June 2016 Pages: 417 - 417

6. Conditional survival after diagnosis with malignant brain and central nervous system tumor in the United States, 1995–2012

   • Paul Farah
   • Rachel Blanda
   • Jill S. Barnholtz-Sloan

   Clinical Study 19 April 2016 Pages: 419 - 429

   

7. Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1–3 metastases

   • Glenn Bauman
   • Slav Yartsev
   • George Rodrigues

   Clinical Study 15 April 2016 Pages: 431 - 436

   

8. Exploratory study of the effect of brain tumors on the default mode network

   • Sukhmanjit Ghumman
   • D. Fortin
   • K. Whittingstall

   Clinical Study 18 April 2016 Pages: 437 - 444

   

9. Brainstem gangliogliomas: prognostic factors, surgical indications and functional outcomes

   • Chang-cun Pan
   • Xin Chen
   • Li-wei Zhang

   Clinical Study 25 April 2016 Pages: 445 - 453

   

10. Brain regions associated with telomerase reverse transcriptase promoter mutations in primary glioblastomas

    • Xing Fan
    • Yinyan Wang
    • Tao Jiang

    Clinical Study 27 May 2016 Pages: 455 - 462

    

11. Intraventricular etoposide safety and toxicity profile in children and young adults with refractory or recurrent malignant brain tumors

    • Kristian W. Pajtler
    • Stephan Tippelt
    • Gudrun Fleischhack

    Clinical Study 04 May 2016 Pages: 463 - 471

12. Use of endocrinological and neurological medication among 5-year survivors of young onset brain tumors

    • Mirja Erika Gunn
    • Tuire Lähdesmäki
    • Päivi Maria Lähteenmäki

    Clinical Study 26 April 2016 Pages: 473 - 479

    

13. Clinical outcome of an alternative fotemustine schedule in elderly patients with recurrent glioblastoma: a mono-institutional retrospective study

    • Giuseppe Lombardi
    • Luisa Bellu
    • Vittorina Zagonel

    Clinical Study 11 May 2016 Pages: 481 - 486

    

14. Update on the evidence-based clinical practice parameter guidelines for the treatment of adults with diffuse low grade glioma: the role of initial chemotherapy

    • Mateo Ziu
    • Jeffrey J. Olson

    Letter to the Editor 06 May 2016 Pages: 487 - 489